YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 56.70
+0.20 (0.35%)
Dec 3, 2025, 1:35 PM CST
YungShin Global Holding Market Cap
YungShin Global Holding has a market cap or net worth of 15.1 billion as of December 3, 2025. Its market cap has increased by 4.42% in one year.
Market Cap
15.10B
Enterprise Value
15.01B
Revenue
8.37B
Ranking
n/a
PE Ratio
15.68
Stock Price
56.70
Market Cap Chart
Since January 4, 2011, YungShin Global Holding's market cap has increased from 10.25B to 15.10B, an increase of 47.36%. That is a compound annual growth rate of 2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 15.10B | 5.19% |
| Dec 31, 2024 | 14.36B | 15.91% |
| Dec 29, 2023 | 12.39B | 1.09% |
| Dec 30, 2022 | 12.25B | 7.10% |
| Dec 30, 2021 | 11.44B | -3.92% |
| Dec 31, 2020 | 11.91B | 4.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 243.49B |
| PharmaEssentia | 190.84B |
| Lotus Pharmaceutical | 82.05B |
| Bora Pharmaceuticals Co., LTD. | 67.80B |
| Lumosa Therapeutics | 36.64B |
| Lin BioScience | 36.61B |
| Oneness Biotech | 32.53B |
| Center Laboratories | 28.33B |